First-Generation Synthetic Cathinones Produce Arrhythmia in Zebrafish Eleutheroembryos: A New Approach Methodology for New Psychoactive Substances Cardiotoxicity Evaluation

Int J Mol Sci. 2023 Sep 8;24(18):13869. doi: 10.3390/ijms241813869.

Abstract

The increasing number of new psychoactive substances (NPS) entering the illicit drug market, especially synthetic cathinones, as well as the risk of cardiovascular complications, is intensifying the need to quickly assess their cardiotoxic potential. The present study aims to evaluate the cardiovascular toxicity and lethality induced by first-generation synthetic cathinones (mephedrone, methylone, and MDPV) and more classical psychostimulants (cocaine and MDMA) in zebrafish embryos using a new approach methodology (NAM). Zebrafish embryos at 4 dpf were exposed to the test drugs for 24 h to identify drug lethality. Drug-induced effects on ventricular and atrial heart rate after 2 h exposure were evaluated, and video recordings were properly analyzed. All illicit drugs displayed similar 24 h LC50 values. Our results indicate that all drugs are able to induce bradycardia, arrhythmia, and atrial-ventricular block (AV block), signs of QT interval prolongation. However, only MDPV induced a different rhythmicity change depending on the chamber and was the most potent bradycardia and AV block-inducing drug compared to the other tested compounds. In summary, our results strongly suggest that the NAM presented in this study can be used for screening NPS for their cardiotoxic effect and especially for their ability to prolong the QT intervals.

Keywords: QT-interval; cardiotoxicity; new psychoactive substances; synthetic cathinones; zebrafish.

MeSH terms

  • Animals
  • Atrial Fibrillation*
  • Atrioventricular Block*
  • Bradycardia
  • Cardiotoxicity / etiology
  • Central Nervous System Stimulants*
  • Illicit Drugs*
  • Synthetic Cathinone
  • Zebrafish

Substances

  • Synthetic Cathinone
  • Central Nervous System Stimulants
  • Illicit Drugs